Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 6 Finished
-
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
Wang, J. (PI), Woyach, J. A. (CoPI) & Wang, M. M. (CoPI)
07/1/20 → 06/30/25
Project: Research
-
Improving BTK Directed Therapy for CLL
Woyach, J. A. (PI) & Johnson, A. J. (CoPI)
07/1/15 → 06/30/21
Project: Research
-
Dual targeting of XPO1 and BTK in B cell malignancies
Lapalombella, R. (PI), Blum, K. A. (CoPI), Byrd, J. C. (CoPI) & Woyach, J. A. (CoPI)
04/21/15 → 03/31/21
Project: Research
-
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
Byrd, J. C. (PI), Johnson, A. J. (CoPI) & Woyach, J. A. (CoPI)
01/1/14 → 12/31/19
Project: Research
-
Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia
Woyach, J. A. (PI)
09/17/13 → 08/31/18
Project: Research
-
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Alsouqi, A., Huang, Y., Christian, B., Reneau, J., Bhat, S. A., Brammer, J., Sawalha, Y., Baiocchi, R. A., Grever, M., Rogers, K. A., Reeser, J., Smith, A., Samorodnitsky, E., Roychowdhury, S., Maddocks, K., Woyach, J. A. & Bond, D., Mar 2026, In: European Journal of Haematology. 116, 3, p. 326-329 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Gordon, B. K., Muhowski, E. M., Singh, J., Ravikrishnan, J., Peris-Cuesta, A., Diaz Rohena, D., Sanchez, J. R., Thangavadivel, S., Benrashid, S., He, A., Marr, A. R., Mitchell, A. D., Urrutia, J. M., Misra, S., Lai, T. H., Yu, L., Walker, B. R., Perry, E., Shukla, S. A. & Grieselhuber, N. R. & 12 others, , Jan 12 2026, In: Blood cancer discovery. 7, 1, p. 85-103 19 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN
Sharman, J. P., Egyed, M., Jurczak, W., Skarbnik, A., Patel, K., Flinn, I. W., Kamdar, M., Munir, T., Walewska, R., Hughes, M., Fogliatto, L. M., Herishanu, Y., Banerji, V., Follows, G., Walker, P., Ghia, P., Janssens, A., Byrd, J. C., Ferrant, E. & Ferrajoli, A. & 7 others, , Sep 11 2025, In: Blood. 146, 11, p. 1276-1285 10 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations -
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study
Roncaglia, E., Gaffo, E., Calabretto, G., Fürstenau, M., Rogers, K. A., Baliakas, P., Cui, C., Miller, C., Haferlach, C., Plevova, K., Oscier, D., Davis, Z., Nguyen-Khac, F., Rigolin, G. M., Athanasiadou, A., Baran-Marszak, F., Valiente, A., Terol, M. J., Abrisqueta, P. & Espinet, B. & 32 others, , Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 74.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study
Visentin, A., Gaffo, E., Fürstenau, M., Rogers, K. A., Panagiotis, B., Cui, C., Miller, C., Haferlach, C., Plevova, K., Oscier, D., Davis, Z., Nguyen-Khac, F., Roncaglia, E., Rigolin, G. M., Athanasiadou, A., Baran-Marszak, F., Valiente, A., Terol, M. J., Abrisqueta, P. & Espinet, B. & 28 others, , Dec 2025, In: Leukemia. 39, 12, p. 2957-2967 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations